Emergomyces - The global rise of new dimorphic fungal pathogens

02 Oct 2019
02 Oct 2019

Claire Hoving
Dr J. Claire Hoving co-authored a review in PLOS Pathogens in September 2019 entitled “Emergomyces - The global rise of new dimorphic fungal pathogens” that discusses the history of the fungi, clinical features and pathogenesis of disease.

Until recently the genus Emergomyces was unknown, it is composed of dimorphic fungi which has the potential to be pathogens to humans. Five species have been described and implicated in diseases caused in immunocompromised people on at least 4 continents.

In Southern Africa the disease, emergomycosis, is now the most commonly diagnosed dimorphic fungal infection.

Dr Hoving and her co-authors review the history of the fungi, their clinical features, pathogenesis of disease, their biology and future research directions.

Read the paper - Emergomyces - The global rise of new dimorphic fungal pathogens